Top in endocrinology: Obesity amid COVID-19, phenotype-based therapy

A speaker at ObesityWeek Interactive presented data that showed many adults with obesity struggled with weight loss and healthy eating during the COVID-19 pandemic. It was the top story in endocrinology last week.

Another top story was about the efficacy of phenotype-based therapy for weight loss.

Read these and more top stories in endocrinology below:

Adults with obesity struggle with weight loss, healthy eating during COVID-19 pandemic

Struggles with losing weight, eating healthy and exercising during the early weeks of the COVID-19 pandemic were reported by more than half of a cohort of adults with obesity, data show. Read more.

Phenotype-based therapy leads to greater weight loss in obesity

A personalized obesity treatment plan based on phenotypes resulted in greater weight loss than standard of care, according to a speaker at ObesityWeek Interactive. Read more.

Old genetic discoveries may reveal ‘new tricks’ for treating obesity

Genetic modifiers — many discovered in the late 1990s — can be “harnessed” to better understand the processes and mechanisms behind weight gain and one day even regulate appetite, according to an expert. Read more.

CGM use ‘reliable, accurate’ for ICU in COVID-19

The use of continuous glucose monitoring technology in critically ill patients with COVID-19 and diabetes is reliable and accurate for real-time glucose trending, according to data from a pilot study. Read more.

NAFLD screening falls short of guidelines for children with obesity

Most children with obesity who are at high risk for non-alcoholic fatty liver disease are not being screened, possibly leading to underdiagnosis of the condition, data show. Read more.